Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Jan 2026 for SELLAS Life Sciences Group, Inc.. Read the official filing
Filing timeline
BuySaleRobert l. Van Nostrand
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Robert l. Van Nostrand: trading record in brief
Filings by Robert l. Van Nostrand span 4 companies, the busiest being Intra-Cellular Therapies, Inc., SELLAS Life Sciences Group, Inc. and Yield10 Bioscience, Inc. Over a trading history stretching from 31 December 2015 to 7 January 2026, the count stands at 32 filings.
On the market, this insider has only ever bought: 1 purchase, €13k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 25 share grants and 5 option exercises.
The record was last updated on 9 January 2026 with a share grant in SELLAS Life Sciences Group, Inc. The last purchase on record was published on 13 June 2025, which is 492 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert l. Van Nostrand
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
50,000 shares0Common StockSEC:0001104659-26-002511:0
10,000 shares@ US$1.48100.0% of flowCommon StockSEC:0001104659-25-059166:0
Canonical exit: 10 Sept 2025 (T+90)
11,340 shares@ US$132.0055.3% of flowCommon StockSEC:0000950170-25-049636:0
12,500 shares0Common StockSEC:0001104659-25-003497:0
83 shares@ US$68.490.2% of flowCommon StockSEC:0000950170-24-080987:0
1,567 sharesCommon StockSEC:0000950170-24-077472:0
20,000 shares@ US$16.8612.6% of flowCommon StockSEC:0000950170-24-076380:0
79 shares@ US$69.200.2% of flowCommon StockSEC:0000950170-24-040166:0
11,924 shares0Common StockSEC:0001628280-24-013923:0
20,000 shares@ US$18.5613.8% of flowCommon StockSEC:0000950170-24-022485:0
6,000 shares0Common StockSEC:0001104659-24-006381:0
18,879 shares0Common StockSEC:0001628280-24-000210:0
76 shares@ US$71.620.2% of flowCommon StockSEC:0000950170-24-001303:0
105 shares@ US$52.090.2% of flowCommon StockSEC:0001209191-23-051143:0
13,868 shares0Common StockSEC:0001121702-23-000056:0
85 shares@ US$63.320.2% of flowCommon StockSEC:0001209191-23-041084:0
2,040 shares0Common StockSEC:0001628280-23-024201:0
10,000 shares@ US$13.054.8% of flowCommon StockSEC:0001209191-23-024899:0
95 shares@ US$54.150.2% of flowCommon StockSEC:0001209191-23-022799:0
1,642 shares0Common StockSEC:0001628280-23-010704:0
2,500 shares0Common StockSEC:0001104659-23-010623:0
97 shares@ US$52.920.2% of flowCommon StockSEC:0001209191-23-000197:0
110 shares@ US$46.530.2% of flowCommon StockSEC:0001209191-22-052716:0
20,000 shares@ US$12.459.7% of flowCommon StockSEC:0001209191-22-045685:0
108 shares@ US$57.080.2% of flowCommon StockSEC:0001209191-22-040571:0
25 of 32 declarations
